Related Experiment Video
Updated: Mar 22, 2026

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
Published on: November 30, 2022
Realizing Our Potential in Biobanking: Disease Advocacy Organizations Enliven Translational Research
Kelly A Edwards1, Sharon F Terry2,3, Dana Gold4
11 Department of Bioethics and Humanities, University of Washington School of Medicine , Seattle, Washington.
Abstract:
Biobanks are increasingly powerful tools used in translational research, and disease advocacy organizations (DAOs) are making their presence known as research drivers and partners. We examined DAO approaches to biobanking to inform how the enterprise of biobanking can grow and become even more impactful in human health. In this commentary, we outline overarching approaches from successful DAO biobanks. These lessons learned suggest principles that can create a more participant-centric approach and illustrate the key roles DAOs can play as partners in research initiatives. DAO approaches to biobanking for translational research include the following: be outcome driven; forge alliances that are unexpected-build bridges to enhance translation; come ready for success; be nimble, flexible, and adaptable; and remember that people matter. Each of these principles led to particular practices that have increased the translational impact of biobank collections. The research practices discussed can inform partnerships in all sectors going forward.
Related Concept Videos
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Pharmacogenomics: Identification of New Drug Targets
Microorganisms in Medicine and Therapeutics
Bioavailability Study Design: Healthy Subjects Versus Patients

